Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Olfactory receptor family 4 subfamily C member 16** (OR4C16) is a member of the olfactory receptor family, part of the G protein-coupled receptor (GPCR) superfamily, responsible for the detection and signal transduction of odorant molecules in the nose[1][5]. Like other olfactory receptors, OR4C16 has a 7-transmembrane domain structure characteristic of GPCRs, arising from a single coding-exon gene[1]. Upon binding odorants, it initiates a neuronal response leading to the perception of smell via G protein-mediated activation of signaling pathways[1][4][5]. Importantly, this gene is a **segregating pseudogene**: some individuals have a functional allele, while others have a non-functional (pseudogene) variant[1]. While olfactory receptors as a group have minor disease associations and may indirectly influence other biological processes, OR4C16 is not known to play a prominent disease role, nor is it a current direct drug target.
Not applicable; no drugs target this receptor directly. In native biology, the mechanism involves G protein-mediated transduction of odorant signals[1][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor family 4 subfamily C member 16 (OR4C16).